UNIGE document Professional Article
previous document  unige:77171  next document
add to browser collection

Effets secondaires systémiques et oropharyngés des corticostéroïdes inhalés

Published in Revue médicale suisse. 2012, vol. 8, no. 363, p. 2219-2223
Abstract The use of inhaled corticosteroids (ICS) is an important component of asthma management. Although their main impact is on airway inflammation, ICS are not devoid of systemic side effects (adrenal insufficiency, osteoporosis, brittle skin, ocular effects, growth retardation). Oropharyngeal side effects are also reported. These effects appear dose and duration dependent. They also vary according to the type of ICS used, its method of administration and drug interactions. It is recommended to titrate ICS to the lowest effective dose, to regularly reconsider their indication and to be aware of drug interactions. In addition, a change in ICS may have a favorable impact on side effects.
Keywords Administration, InhalationAnti-Asthmatic Agents/administration & dosage/adverse effects/therapeutic useAsthma/drug therapyDose-Response Relationship, DrugDrug InteractionsGlucocorticoids/administration & dosage/adverse effects/therapeutic useHumansOropharynx/drug effects/pathologyPharyngeal Diseases/chemically inducedTime Factors
PMID: 23240297
Full text
Article (Published version) (549 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Groupe Gasche-Soccal Paola (958)
(ISO format)
ROCHAT, Tamara, JANSSENS, Jean-Paul. Effets secondaires systémiques et oropharyngés des corticostéroïdes inhalés. In: Revue médicale suisse, 2012, vol. 8, n° 363, p. 2219-2223. https://archive-ouverte.unige.ch/unige:77171

204 hits

1 download


Deposited on : 2015-11-11

Export document
Format :
Citation style :